These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [The pharmacology of drugs used for the treatment of cardiovascular disorders]. Klaus W Klin Anasthesiol Intensivther; 1976 Apr; (11):106-22. PubMed ID: 11364 [No Abstract] [Full Text] [Related]
4. [Blockage of beta-adrenergic receptors in the clinical course of the cardio-vascular system (review of the literature)]. Gorodinskaia VIa; Simon IB Vrach Delo; 1967 Nov; 11():24-31. PubMed ID: 4392169 [No Abstract] [Full Text] [Related]
5. [Stimulation and blocking of adrenergic receptors in the therapy of cardiovascular diseases]. Cárdenas M Gac Med Mex; 1981 Dec; 117(12):466-71. PubMed ID: 6123459 [No Abstract] [Full Text] [Related]
8. [Beta blockaders and hypertension]. Lund-Larsen PG; Naess K Tidsskr Nor Laegeforen; 1971 Jan; 91(3):222-4. PubMed ID: 4395485 [No Abstract] [Full Text] [Related]
9. Beta adrenergic blockade: a new class of cardiovascular drugs. Robinson CW J Okla State Med Assoc; 1965 Oct; 58(10):469-70. PubMed ID: 5319099 [No Abstract] [Full Text] [Related]
10. The clinical meaning of cardiovascular beta-adrenergic receptors. Frohlich ED; Page IH Physiol Pharmacol Physicians; 1966 Nov; 1(11):1-5. PubMed ID: 5978542 [No Abstract] [Full Text] [Related]
11. [Clinical effect of doberol. Significance for diagnosis and therapy]. Hähnel J Med Welt; 1971 Mar; 13():512-6. PubMed ID: 5563475 [No Abstract] [Full Text] [Related]
12. [Action of and inhibitor of adrenergic beta-receptors on the tachycardia of hyperthyroidism and on idiopathic tachycardia]. Linquette M; May JP; Mesmacque R; Belbenoit C; Luez G Rev Fr Endocrinol Clin; 1968; 9(1):31-9. PubMed ID: 5687799 [No Abstract] [Full Text] [Related]
14. [Intrinsic sympathomimetic activity of adrenergic beta receptor blockaders and its role in various clinical situations]. Bubiński R Pol Tyg Lek; 1984 Dec 17-31; 39(51-52):1713-6. PubMed ID: 6151656 [No Abstract] [Full Text] [Related]
16. The response of thyrotoxic tachycardia to Trasicor, a new beta adrenergic blocking agent. Darsinos J; Katsilambros N; Papamatheou M; Papadoyanakis N Curr Ther Res Clin Exp; 1968 Dec; 10(12):626-30. PubMed ID: 4972758 [No Abstract] [Full Text] [Related]
17. Control of tachycardia and hypertension following coronary artery bypass graft surgery: efficacy and haemodynamic effects of esmolol. Tempe DK; Mulchandani P; Tandon MS; Mehta N; Tomar AS; Banerjee A; Khanna SK Indian Heart J; 1999; 51(3):294-300. PubMed ID: 10624069 [TBL] [Abstract][Full Text] [Related]
18. [Reimbursement for blockaders in angina pectoris]. Tidsskr Nor Laegeforen; 1971 Jul; 91(19):1479. PubMed ID: 4398227 [No Abstract] [Full Text] [Related]
19. Adrenergic blocking agents in cardiovascular disease. I. Margolies MP Pa Med; 1968 Aug; 71(8):54. PubMed ID: 5662373 [No Abstract] [Full Text] [Related]
20. The role of the new beta-blockers in treating cardiovascular disease. Weber MA Am J Hypertens; 2005 Dec; 18(12 Pt 2):169S-176S. PubMed ID: 16373195 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]